This report contains market size and forecasts of Glutamate Receptor Ionotropic NMDA 2B in global, including the following market information:
Global Glutamate Receptor Ionotropic NMDA 2B Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Glutamate Receptor Ionotropic NMDA 2B Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Glutamate Receptor Ionotropic NMDA 2B companies in 2020 (%)
The global Glutamate Receptor Ionotropic NMDA 2B market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glutamate Receptor Ionotropic NMDA 2B manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glutamate Receptor Ionotropic NMDA 2B Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, By Type, 2020 (%)
JNJ-0808
Neu-2000
NP-10679
NP-11948
Radiprodil
Others
Global Glutamate Receptor Ionotropic NMDA 2B Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, By Application, 2020 (%)
Acute Ischemic Stroke
Autism
Brain Ischemia
Burns
Others
Global Glutamate Receptor Ionotropic NMDA 2B Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Glutamate Receptor Ionotropic NMDA 2B Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glutamate Receptor Ionotropic NMDA 2B revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Glutamate Receptor Ionotropic NMDA 2B revenues share in global market, 2020 (%)
Key companies Glutamate Receptor Ionotropic NMDA 2B sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Glutamate Receptor Ionotropic NMDA 2B sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Glutamate Receptor Ionotropic NMDA 2B Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glutamate Receptor Ionotropic NMDA 2B Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glutamate Receptor Ionotropic NMDA 2B Overall Market Size
2.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size: 2021 VS 2027
2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Glutamate Receptor Ionotropic NMDA 2B Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Glutamate Receptor Ionotropic NMDA 2B Players in Global Market
3.2 Top Global Glutamate Receptor Ionotropic NMDA 2B Companies Ranked by Revenue
3.3 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Companies
3.4 Global Glutamate Receptor Ionotropic NMDA 2B Sales by Companies
3.5 Global Glutamate Receptor Ionotropic NMDA 2B Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Glutamate Receptor Ionotropic NMDA 2B Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glutamate Receptor Ionotropic NMDA 2B Players in Global Market
3.8.1 List of Global Tier 1 Glutamate Receptor Ionotropic NMDA 2B Companies
3.8.2 List of Global Tier 2 and Tier 3 Glutamate Receptor Ionotropic NMDA 2B Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Market Size Markets, 2021 & 2027
4.1.2 JNJ-0808
4.1.3 Neu-2000
4.1.4 NP-10679
4.1.5 NP-11948
4.1.6 Radiprodil
4.1.7 Others
4.2 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Revenue & Forecasts
4.2.1 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2016-2021
4.2.2 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2022-2027
4.2.3 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2016-2027
4.3 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Sales & Forecasts
4.3.1 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2016-2021
4.3.2 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2022-2027
4.3.3 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2016-2027
4.4 By Type - Global Glutamate Receptor Ionotropic NMDA 2B Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Market Size, 2021 & 2027
5.1.2 Acute Ischemic Stroke
5.1.3 Autism
5.1.4 Brain Ischemia
5.1.5 Burns
5.1.6 Others
5.2 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Revenue & Forecasts
5.2.1 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2016-2021
5.2.2 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2022-2027
5.2.3 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2016-2027
5.3 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Sales & Forecasts
5.3.1 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2016-2021
5.3.2 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2022-2027
5.3.3 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2016-2027
5.4 By Application - Global Glutamate Receptor Ionotropic NMDA 2B Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Market Size, 2021 & 2027
6.2 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue & Forecasts
6.2.1 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2016-2021
6.2.2 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue, 2022-2027
6.2.3 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share, 2016-2027
6.3 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Sales & Forecasts
6.3.1 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2016-2021
6.3.2 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Sales, 2022-2027
6.3.3 By Region - Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Glutamate Receptor Ionotropic NMDA 2B Revenue, 2016-2027
6.4.2 By Country - North America Glutamate Receptor Ionotropic NMDA 2B Sales, 2016-2027
6.4.3 US Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.4.4 Canada Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.4.5 Mexico Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Glutamate Receptor Ionotropic NMDA 2B Revenue, 2016-2027
6.5.2 By Country - Europe Glutamate Receptor Ionotropic NMDA 2B Sales, 2016-2027
6.5.3 Germany Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.5.4 France Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.5.5 U.K. Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.5.6 Italy Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.5.7 Russia Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.5.8 Nordic Countries Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.5.9 Benelux Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Glutamate Receptor Ionotropic NMDA 2B Revenue, 2016-2027
6.6.2 By Region - Asia Glutamate Receptor Ionotropic NMDA 2B Sales, 2016-2027
6.6.3 China Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.6.4 Japan Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.6.5 South Korea Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.6.6 Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.6.7 India Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Glutamate Receptor Ionotropic NMDA 2B Revenue, 2016-2027
6.7.2 By Country - South America Glutamate Receptor Ionotropic NMDA 2B Sales, 2016-2027
6.7.3 Brazil Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.7.4 Argentina Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales, 2016-2027
6.8.3 Turkey Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.8.4 Israel Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.8.5 Saudi Arabia Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
6.8.6 UAE Glutamate Receptor Ionotropic NMDA 2B Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 BioCrea GmbH
7.1.1 BioCrea GmbH Corporate Summary
7.1.2 BioCrea GmbH Business Overview
7.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.1.4 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2016-2021)
7.1.5 BioCrea GmbH Key News
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporate Summary
7.2.2 Bristol-Myers Squibb Company Business Overview
7.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.2.4 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2016-2021)
7.2.5 Bristol-Myers Squibb Company Key News
7.3 Cerecor Inc.
7.3.1 Cerecor Inc. Corporate Summary
7.3.2 Cerecor Inc. Business Overview
7.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.3.4 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2016-2021)
7.3.5 Cerecor Inc. Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.4.4 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 Luc Therapeutics, Inc.
7.5.1 Luc Therapeutics, Inc. Corporate Summary
7.5.2 Luc Therapeutics, Inc. Business Overview
7.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.5.4 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2016-2021)
7.5.5 Luc Therapeutics, Inc. Key News
7.6 NeurOp, Inc
7.6.1 NeurOp, Inc Corporate Summary
7.6.2 NeurOp, Inc Business Overview
7.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.6.4 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2016-2021)
7.6.5 NeurOp, Inc Key News
7.7 Novartis AG
7.7.1 Novartis AG Corporate Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.4.4 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2016-2021)
7.7.5 Novartis AG Key News
7.8 UCB S.A.
7.8.1 UCB S.A. Corporate Summary
7.8.2 UCB S.A. Business Overview
7.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Major Product Offerings
7.8.4 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales and Revenue in Global (2016-2021)
7.8.5 UCB S.A. Key News
8 Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity, Analysis
8.1 Global Glutamate Receptor Ionotropic NMDA 2B Production Capacity, 2016-2027
8.2 Glutamate Receptor Ionotropic NMDA 2B Production Capacity of Key Manufacturers in Global Market
8.3 Global Glutamate Receptor Ionotropic NMDA 2B Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glutamate Receptor Ionotropic NMDA 2B Supply Chain Analysis
10.1 Glutamate Receptor Ionotropic NMDA 2B Industry Value Chain
10.2 Glutamate Receptor Ionotropic NMDA 2B Upstream Market
10.3 Glutamate Receptor Ionotropic NMDA 2B Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glutamate Receptor Ionotropic NMDA 2B Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Glutamate Receptor Ionotropic NMDA 2B in Global Market
Table 2. Top Glutamate Receptor Ionotropic NMDA 2B Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Share by Companies, 2016-2021
Table 5. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Glutamate Receptor Ionotropic NMDA 2B Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Type
Table 9. List of Global Tier 1 Glutamate Receptor Ionotropic NMDA 2B Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glutamate Receptor Ionotropic NMDA 2B Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
BioCrea GmbH
Bristol-Myers Squibb Company
Cerecor Inc.
Johnson & Johnson
Luc Therapeutics, Inc.
NeurOp, Inc
Novartis AG
UCB S.A.